Li Zhiqiang, Hailemariam Tiruneh K, Zhou Hongwen, Li Yan, Duckworth Dale C, Peake David A, Zhang Youyan, Kuo Ming-Shang, Cao Guoqing, Jiang Xian-Cheng
Department of Anatomy and Cell Biology, State University of New York Downstate Medical Center, 450 Clarkson Ave. Box 5, Brooklyn, NY 11203, USA.
Biochim Biophys Acta. 2007 Sep;1771(9):1186-94. doi: 10.1016/j.bbalip.2007.05.007. Epub 2007 Jun 6.
Sphingomyelin plays a very important role both in cell membrane formation that may well have an impact on the development of diseases like atherosclerosis and diabetes. However, the molecular mechanism that governs intracellular and plasma membrane SM levels is largely unknown. Recently, two isoforms of sphingomyelin synthase (SMS1 and SMS2), the last enzyme for SM de novo synthesis, have been cloned. We have hypothesized that SMS1 and SMS2 are the two most likely candidates responsible for the SM levels in the cells and on the plasma membrane. To test this hypothesis, cultured cells were treated with tricyclodecan-9-yl-xanthogenate (D609), an inhibitor of SMS, or with SMS1 and SMS2 siRNAs. Cells were then pulsed with [14C]-L-serine (a precursor of all sphingolipids). SMS activity and [14C]-SM in the cells were monitored. We found that SMS activity was significantly decreased in cells after D609 or SMS siRNA treatment, compared with controls. SMS inhibition by D609 or SMS siRNAs significantly decreased intracellular [14C]-SM levels. We measured cellular lipid levels, including SM, ceramide, phosphatidylcholine, and diacylglycerol and found that SMS1 and SMS2 siRNA treatment caused a significant decrease of SM levels (20% and 11%, respectively), compared to control siRNA treatment; SMS1 but not SMS2 siRNA treatment caused a significant increase of ceramide levels (10%). There was a decreasing tendency for diacylglycerol levels after both SMS1 and SMS2 siRNA treatment, however, it was not statistical significant. As shown by lipid rafts isolation and lipid determination, SMS1 and SMS2 siRNA treatment led to a decrease of SM content in detergent-resistant lipid rafts on the cell membrane. Furthermore, SMS1 and SMS2 siRNA-treated cells had a stronger resistance than did control siRNA-treated cells to lysenin (a protein that causes cell lysis due to its affinity for plasma membrane SM). These results indicate that both SMS1 and SMS2 contribute to SM de novo synthesis and control SM levels in the cells and on the cell membrane including plasma membrane, implying an important relationship between SMS activity and cell functions.
鞘磷脂在细胞膜形成过程中发挥着非常重要的作用,这很可能对动脉粥样硬化和糖尿病等疾病的发展产生影响。然而,调控细胞内和质膜鞘磷脂水平的分子机制在很大程度上尚不清楚。最近,鞘磷脂合酶的两种同工型(SMS1和SMS2),即鞘磷脂从头合成的最后一种酶,已被克隆出来。我们推测,SMS1和SMS2是最有可能负责细胞内和质膜鞘磷脂水平的两个候选者。为了验证这一假设,用三环癸烷-9-基-黄原酸酯(D609),一种SMS的抑制剂,或用SMS1和SMS2的小干扰RNA(siRNA)处理培养细胞。然后用[14C]-L-丝氨酸(所有鞘脂的前体)对细胞进行脉冲标记。监测细胞中的SMS活性和[14C]-鞘磷脂水平。我们发现,与对照组相比,D609或SMS siRNA处理后的细胞中SMS活性显著降低。D609或SMS siRNA对SMS的抑制作用显著降低了细胞内[14C]-鞘磷脂水平。我们测量了细胞脂质水平,包括鞘磷脂、神经酰胺、磷脂酰胆碱和二酰甘油,发现与对照siRNA处理相比,SMS1和SMS2 siRNA处理导致鞘磷脂水平显著降低(分别为20%和11%);SMS1而非SMS2 siRNA处理导致神经酰胺水平显著升高(10%)。SMS1和SMS2 siRNA处理后二酰甘油水平有下降趋势,然而,差异无统计学意义。如脂筏分离和脂质测定所示,SMS1和SMS2 siRNA处理导致细胞膜上耐去污剂脂筏中鞘磷脂含量降低。此外,与对照siRNA处理的细胞相比,SMS1和SMS2 siRNA处理的细胞对溶血素(一种由于其对质膜鞘磷脂的亲和力而导致细胞裂解的蛋白质)具有更强的抗性。这些结果表明,SMS1和SMS2都有助于鞘磷脂的从头合成,并控制细胞内和包括质膜在内的细胞膜上的鞘磷脂水平,这意味着SMS活性与细胞功能之间存在重要关系。